TL;DR
This study presents the first high-resolution map of N-glycosylation in aging mouse ovaries, revealing significant changes in glycan structures and their associated proteins. These alterations are linked to key biological processes like fertility decline, immune response, and cell death, offering a new perspective on the molecular mechanisms of ovarian aging beyond traditional proteomic and transcriptomic studies.
What Problem Does This Paper Address?
Ovarian aging is a critical factor in female reproductive health and overall aging, yet its underlying molecular mechanisms are not fully understood. While other "omics" approaches like transcriptomics and proteomics have provided insights, the role of glycosylation – a crucial post-translational modification – has been largely unexplored in this context. Glycosylation is known to be vital for many cellular processes, including reproduction, and its dysregulation is implicated in various diseases. The challenge lies in the complexity of glycans and the difficulty in analyzing them at a site-specific level, especially in complex biological samples like ovaries. This paper aims to fill this gap by providing a detailed, site-specific N-glycoproteomic landscape of aging mouse ovaries to uncover the molecular changes associated with this process.
Methods
The researchers employed a sophisticated multi-omics approach. Key techniques include:
- Tandem Mass Tag (TMT) Labeling: Used for quantitative comparison of proteins and glycopeptides between young (2-month-old) and middle-aged (12-month-old) mouse ovaries.
- High-Resolution N-Glycoproteomics: The core of the study, utilizing a proprietary method (StrucGP software) that combines characteristic B and Y ions in tandem mass spectra (MS/MS) with low HCD collision energy to identify and interpret site-specific N-glycan structures. This approach allows for high-throughput and high-resolution glycoproteomic analysis of intact glycopeptides.
- Intact Glycopeptide Enrichment: Specialized methods were used to isolate intact glycopeptides from complex biological samples.
- Phosphoproteomics and Global Proteomics: These were integrated with glycoproteomics to understand the interplay between glycosylation, phosphorylation, and overall protein expression changes during ovarian aging.
- Bioinformatic Analyses: Principal Component Analysis (PCA) for sample clustering, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for functional enrichment, and protein-protein interaction (PPI) network analysis to identify key molecular players.
- Histological Staining: Techniques like Hematoxylin and Eosin (H&E), Masson's Trichrome, Sirius Red, and Periodic Acid-Schiff (PAS) staining were used to assess structural changes, fibrosis, and overall glycan accumulation in ovarian tissues.
- Immunohistochemistry and Lectin Histochemistry: Used to validate specific glycan-related protein expressions and the presence of LacdiNAc structures.
The novelty lies in the application of their advanced StrucGP-based glycoproteomic approach for a comprehensive, site-specific analysis of ovarian aging, integrating it with other omics data.
Datasets
The study utilized mouse ovary tissues from two age groups: young (2-month-old) and middle-aged (12-month-old). These tissues were processed for quantitative glycoproteomic, phosphoproteomic, and global proteomic analyses. The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium (iProX) with the dataset identifier PXD056126.
Key Insights and Ideas
- Glycosylation is a Major Player in Ovarian Aging: The study strongly suggests that changes in glycosylation are not just a consequence but a significant driver of ovarian aging, often occurring independently of changes in protein expression.
- Distinct Glycan Signatures in Ovarian Subcellular Components: The egg coat (zona pellucida) exhibits unique N-glycan profiles, characterized by a high proportion of complex glycans, core fucosylation, and LacdiNAc branches, differentiating it from other cellular components.
- Three Major Glycosylation Alterations in Aging:
- Core Fucosylation Changes: Frequently altered, linked to cell adhesion and immune/stress responses.
- LacdiNAc Glycan Decline: Significantly reduced, particularly on zona pellucida glycoproteins, potentially contributing to fertility decline.
- Sialylated Glycan Increase: Elevated Neu5Ac and Neu5Gc levels, playing distinct roles in immune activation and responses.
- Glycosylation vs. Phosphorylation in Signaling: Glycosylation, particularly on cell surface glycoproteins, appears to act upstream of phosphorylation (which is more prominent in the cytosol/nucleus) in regulating key signaling pathways involved in ovarian aging.
- Glycans Differentiate Cell Death Pathways: The study provides the first glycoproteomic evidence that ferroptosis and apoptosis, two critical cell death pathways in ovarian aging, are associated with distinct glycan profiles (sialylated for ferroptosis, oligo-mannose for apoptosis).
Key Results
- Comprehensive Glycoproteomic Map: Identified 2270 N-glycoproteins and 3542 N-glycosites with high confidence.
- Differential Glycopeptides: Identified 1556 upregulated and 293 downregulated glycopeptides in aged ovaries.
- Glycosylation-Level Changes Dominate: 83% of altered glycoproteins showed changes at the glycosylation level, not protein expression.
- LacdiNAc Decline Linked to Zona Pellucida Proteins: Decreased LacdiNAc structures were observed on key zona pellucida proteins (ZP2, ZP3), correlating with their reduced expression and potential fertility impact.
- Sialylation Increases and Differentiates Immune Roles: Increased sialylation was observed, with Neu5Ac and Neu5Gc-modified glycoproteins playing distinct roles in immune regulation.
- Pathway Involvement: Altered glycoproteins were enriched in pathways like complement and coagulation cascade, antigen processing, ferroptosis, and apoptosis.
Limitations and Future Work
- Mouse Model Limitations: The authors acknowledge that while mice are a valuable model, direct translation of findings to human ovarian aging may be limited, especially considering humans lack Neu5Gc.
- Need for Orthogonal Validation: Further functional and mechanistic studies are required, with orthogonal validation of site-specific glycosylation changes.
- Investigating Sialic Acid Roles: The precise roles of Neu5Ac and Neu5Gc in immune processes and their functional differences require further investigation.
- Glycosylation in Cell Death Pathways: The exact mechanisms by which glycosylation regulates ferroptosis and apoptosis need more in-depth study.
- Future Directions: The study opens avenues for exploring N-glycan features as potential biomarkers for ovarian aging and differentiating cell death pathways, and for developing targeted therapeutic strategies.
Summary updated